T Man Pharmaceutical PCL
SET:TMAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
TH |
|
L
|
Lexeo Therapeutics Inc
NASDAQ:LXEO
|
US |
Multiples-Based Value
The Multiples-Based Value of one TMAN stock under the Base Case scenario is 21.05 THB. Compared to the current market price of 12.8 THB, T Man Pharmaceutical PCL is Undervalued by 39%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
TMAN Competitors Multiples
T Man Pharmaceutical PCL Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TH |
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
5.1B THB | 2 | 9.8 | 7.4 | 9 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
265.7B USD | 0 | 0 | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 351.6 | 4 020.7 | 3 417.4 | 3 537.2 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
100.9B ZAR | 5.6 | 10.4 | 14.2 | 14.3 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
66.6B USD | 0 | 37 628.6 | -17 619.9 | -17 619.9 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
59.6B USD | 0 | 0 | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
36.7B CHF | 0 | 0 | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
32.8B EUR | 1.1 | 182.3 | 33.6 | 70.3 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
35.4B USD | 15 | -3 295.6 | -4 363.8 | -701.1 | |
| US |
R
|
Reddit Inc
NYSE:RDDT
|
30.3B USD | 14 | 58.2 | 61.9 | 64.1 |